Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1967 2
1968 1
1969 1
1970 1
1972 3
1973 3
1974 1
1975 1
1976 1
1977 1
1978 2
1979 6
1980 6
1981 1
1982 7
1983 2
1984 1
1985 2
1988 3
1989 2
1990 1
1991 2
1992 4
1993 2
1995 2
1997 4
1998 1
1999 2
2000 5
2001 2
2002 7
2003 3
2004 3
2005 6
2006 8
2007 12
2008 11
2009 12
2010 15
2011 20
2012 19
2013 33
2014 28
2015 34
2016 37
2017 22
2018 31
2019 33
2020 46
2021 47
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

444 results
Results by year
Filters applied: . Clear all
Page 1
An update on adjunctive treatment options for bipolar disorder.
Dean OM, Gliddon E, Van Rheenen TE, Giorlando F, Davidson SK, Kaur M, Ngo TT, Williams LJ. Dean OM, et al. Among authors: williams lj. Bipolar Disord. 2018 Mar;20(2):87-96. doi: 10.1111/bdi.12601. Epub 2018 Jan 25. Bipolar Disord. 2018. PMID: 29369487 Review.
Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy.
Peng W, Chen JQ, Liu C, Malu S, Creasy C, Tetzlaff MT, Xu C, McKenzie JA, Zhang C, Liang X, Williams LJ, Deng W, Chen G, Mbofung R, Lazar AJ, Torres-Cabala CA, Cooper ZA, Chen PL, Tieu TN, Spranger S, Yu X, Bernatchez C, Forget MA, Haymaker C, Amaria R, McQuade JL, Glitza IC, Cascone T, Li HS, Kwong LN, Heffernan TP, Hu J, Bassett RL Jr, Bosenberg MW, Woodman SE, Overwijk WW, Lizée G, Roszik J, Gajewski TF, Wargo JA, Gershenwald JE, Radvanyi L, Davies MA, Hwu P. Peng W, et al. Among authors: williams lj. Cancer Discov. 2016 Feb;6(2):202-16. doi: 10.1158/2159-8290.CD-15-0283. Epub 2015 Dec 8. Cancer Discov. 2016. PMID: 26645196 Free PMC article.
Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy.
Cascone T, McKenzie JA, Mbofung RM, Punt S, Wang Z, Xu C, Williams LJ, Wang Z, Bristow CA, Carugo A, Peoples MD, Li L, Karpinets T, Huang L, Malu S, Creasy C, Leahey SE, Chen J, Chen Y, Pelicano H, Bernatchez C, Gopal YNV, Heffernan TP, Hu J, Wang J, Amaria RN, Garraway LA, Huang P, Yang P, Wistuba II, Woodman SE, Roszik J, Davis RE, Davies MA, Heymach JV, Hwu P, Peng W. Cascone T, et al. Among authors: williams lj. Cell Metab. 2018 May 1;27(5):977-987.e4. doi: 10.1016/j.cmet.2018.02.024. Epub 2018 Apr 5. Cell Metab. 2018. PMID: 29628419 Free PMC article.
The Glutaminase Inhibitor CB-839 (Telaglenastat) Enhances the Antimelanoma Activity of T-Cell-Mediated Immunotherapies.
Varghese S, Pramanik S, Williams LJ, Hodges HR, Hudgens CW, Fischer GM, Luo CK, Knighton B, Tan L, Lorenzi PL, Mackinnon AL, McQuade JL, Hailemichael Y, Roszik J, Peng W, Vashisht Gopal YN. Varghese S, et al. Among authors: williams lj. Mol Cancer Ther. 2021 Mar;20(3):500-511. doi: 10.1158/1535-7163.MCT-20-0430. Epub 2020 Dec 23. Mol Cancer Ther. 2021. PMID: 33361272 Free PMC article.
444 results